SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-262866
Filing Date
2019-10-04
Accepted
2019-10-04 17:16:07
Documents
12
Period of Report
2019-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d810913d8k.htm   iXBRL 8-K 24468
  Complete submission text file 0001193125-19-262866.txt   142885

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA myok-20190930.xsd EX-101.SCH 3072
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20190930_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20190930_pre.xml EX-101.PRE 10954
12 EXTRACTED XBRL INSTANCE DOCUMENT d810913d8k_htm.xml XML 3254
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 191139213
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences